Retrospective interrupted time series examining hypertension and diabetes medicines usage following changes in patient cost sharing in the 'Farmácia Popular' programme in Brazil.
Emmerick, Isabel Cristina Martins; Campos, Monica Rodrigues; Luiza, Vera Lucia; Chaves, Luisa Arueira; Bertoldi, Andrea Dâmaso; Ross-Degnan, Dennis.
; 7(11): e017308, 2017 Nov 03.
Artigo em Inglês | MEDLINE | ID: mdl-29101135
Saving Money On Meds Cut your Rx costs with these tips.
Trends in Diabetes Treatment and Monitoring among Medicare Beneficiaries.
Ideglira is Associated With Improved Short-Term Clinical Outcomes and Cost Savings Compared with Insulin Glargine U100 Plus Insulin Aspart in the U.S.
Novel Devices for Delivering Diabetes Medications: Their Value and Some Coverage Considerations.
Myopic and Forward Looking Behavior in Branded Oral Anti-Diabetic Medication Consumption: An Example from Medicare Part D.
Access to insulin: applying the concept of security of supply to medicines.
Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?
Regional variation in use of a new class of antidiabetic medication among medicare beneficiaries: the case of incretin mimetics.
Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending.
Brand-name prescription drug use among Veterans Affairs and Medicare Part D patients with diabetes: a national cohort comparison.